Principal Securities’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$424K Buy
4,190
+70
+2% +$7.25K 0.01% 1159
2026
Q1
$399K Buy
4,120
+942
+30% +$96.6K 0.01% 1076
2025
Q4
$337K Sell
3,178
-76
-2% -$8.81K 0.01% 1090
2025
Q3
$413K Buy
3,254
+253
+8% +$30.1K 0.01% 981
2025
Q2
$368K Buy
3,001
+794
+36% +$90.7K 0.01% 987
2025
Q1
$204K Hold
2,207
﹤0.01% 1131
2024
Q4
$204K Buy
2,207
+277
+14% +$27.2K ﹤0.01% 1130
2024
Q3
$187K Buy
1,930
+38
+2% +$3.42K ﹤0.01% 1132
2024
Q2
$162K Buy
1,892
+127
+7% +$10.7K ﹤0.01% 1127
2024
Q1
$146K Buy
1,765
+1,387
+367% +$102K ﹤0.01% 1137
2023
Q4
$25.2K Buy
+378
New +$24.5K ﹤0.01% 1803

Other funds holding EHC

Principal Securities's EHC Position: Q2 2026 in Review

Principal Securities increased its Encompass Health (EHC) stake by 1.7% in Q2 2026, buying an estimated $7.25K and bringing the position to 4,190 shares worth $424K. The position accounts for 0.01% of the portfolio, ranked #1159.

Principal Securities first reported a position in EHC in Q4 2023 and has held it in 11 quarters since. 597 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Principal Securities held 4,190 shares of Encompass Health worth $424K as of Q2 2026.
  • Principal Securities bought 70 Encompass Health shares in Q2 2026, an estimated $7.25K.
  • Encompass Health made up 0.01% of Principal Securities's portfolio in Q2 2026, its #1159 holding.
  • Principal Securities first reported a position in Encompass Health in Q4 2023 and has held it in 11 quarters since.
  • 597 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Principal Securities's 13F filing for Q2 2026, filed 4 Aug 2026.